Integrin-free tetraspanin CD151 can inhibit tumor cell motility upon clustering and is a clinical indicator of prostate cancer progression.
about
CD151-A Striking Marker for Cancer TherapyDirectional cell movement through tissues is controlled by exosome secretionHigh EGFR_1 Inside-Out Activated Inflammation-Induced Motility through SLC2A1-CCNB2-HMMR-KIF11-NUSAP1-PRC1-UBE2C.Regulation of FAK Activity by Tetraspan Proteins: Potential Clinical Implications in Cancer.Flipping the switch: integrin switching provides metastatic competenceMetastasis as a therapeutic target in prostate cancer: a conceptual framework.Porphyrin Nanodroplets: Sub-micrometer Ultrasound and Photoacoustic Contrast Imaging Agents.Lack of CD151/integrin α3β1 complex is predictive of poor outcome in node-negative lobular breast carcinoma: opposing roles of CD151 in invasive lobular and ductal breast cancers.CD151 promotes α3β1 integrin-dependent organization of carcinoma cell junctions and restrains collective cell invasionCD151-mediated adhesion is crucial to osteosarcoma pulmonary metastasis.Metastasis review: from bench to bedside.New insights into the tetraspanin Tspan5 using novel monoclonal antibodies.Pseudomonas aeruginosa lectin LecB inhibits tissue repair processes by triggering β-catenin degradation.Joint features and complementarities of Tspan8 and CD151 revealed in knockdown and knockout models.Expression of cluster of differentiation 151 prior to and following transcatheter arterial chemoembolization therapy in patients with hepatocellular carcinoma and its association with clinicopathological characteristics.Quantitative in vivo whole genome motility screen reveals novel therapeutic targets to block cancer metastasis.Extracellular vesicles with altered tetraspanin CD9 and CD151 levels confer increased prostate cell motility and invasion.Immune Targeting of Tetraspanins Involved in Cell Invasion and Metastasis.
P2860
Q27024979-19B8BB56-E562-4DD9-92F6-E0757ABBD332Q30650966-DA2F3B7D-8222-4A69-96D7-DC6F28B1F3CEQ30651265-4F2EAB70-F0EF-40DC-B895-8B3652BF1DDAQ33559314-F492C51F-52EA-4CF5-9448-F731E3A68DE4Q34402680-616C1FC5-B518-4FAB-BD35-BAE2EBB739DDQ34448162-A048D8DA-F6E1-4D57-B1CC-C0F424438B34Q35860193-5E47D1FF-6C5B-462B-8A02-8DC0A54F8ECAQ36750641-3D98B924-0BB2-48E7-BE9F-B171ABF8F141Q36838910-99C9AF00-263C-40ED-851D-F7BA5C6ACE1FQ37645073-2AAD6706-CA3D-475D-9978-2DDFEF46E819Q38237985-E6D0A9BF-0A34-4390-867A-00BBE7DE08EEQ38706629-DA91ECF0-44D8-495D-9C22-3AFAB471D3A9Q38795279-04CE4C22-2D98-4AB5-A032-B7AB568941A9Q39241513-F8CCD5BF-EDDC-4738-A471-2C5C20B87DA4Q49386865-6312EC9F-AC87-4878-A4DF-D8B82C2EACE1Q55315550-66BAD8EB-FC9F-4916-9892-CDF23D924502Q55340407-5D299BB9-2477-4687-8F6E-AA4A27367E54Q55467140-3A962FE0-8DFA-4E13-BF16-2A10036AA7AF
P2860
Integrin-free tetraspanin CD151 can inhibit tumor cell motility upon clustering and is a clinical indicator of prostate cancer progression.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Integrin-free tetraspanin CD15 ...... f prostate cancer progression.
@en
Integrin-free tetraspanin CD15 ...... f prostate cancer progression.
@nl
type
label
Integrin-free tetraspanin CD15 ...... f prostate cancer progression.
@en
Integrin-free tetraspanin CD15 ...... f prostate cancer progression.
@nl
prefLabel
Integrin-free tetraspanin CD15 ...... f prostate cancer progression.
@en
Integrin-free tetraspanin CD15 ...... f prostate cancer progression.
@nl
P2093
P2860
P1433
P1476
Integrin-free tetraspanin CD15 ...... of prostate cancer progression
@en
P2093
Andrew K Williams
Carlos H Martínez
Catalina Vasquez
Celestial Jones-Paris
Giovanna A Giannico
John D Lewis
Jose A Gomez-Lemus
Joseph L Chin
Katie E Hebron
Shanna A Arnold
P2860
P304
P356
10.1158/0008-5472.CAN-13-0275
P407
P577
2013-11-12T00:00:00Z